COMPOUNDS FOR THE TREATMENT OF MYOTONIC DYSTROPHY

The present invention relates to a compound of the following formula (I), (see formula I) provided that this compound is not caffeine, for use in the treatment of myotonic dystrophy type 1 and type 2. The present invention also relates to compositions comprising the compound of formula (I). The pres...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CASTELLS BOLIART, JOSEP, ARTERO ALLEPUZ, RUBEN, KONIECZNY, PIOTR, LLAMUSI TROISI, BEATRIZ, PASCUAL GILABERT, MARTA, LOPEZ GONZALEZ, ALEJANDRO, ESTRADA TEJEDOR, ROGER, BORRELL BILBAO, JOSE IGNACIO, BARGIELA SCHONBRUNN, ARIADNA, TEIXIDO CLOSA, JORDI
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a compound of the following formula (I), (see formula I) provided that this compound is not caffeine, for use in the treatment of myotonic dystrophy type 1 and type 2. The present invention also relates to compositions comprising the compound of formula (I). The present invention further relates to new compounds which are dimers of compounds of formula (I). La présente invention concerne un composé de formule (I), ce composé n'étant pas de la caféine, à employer pour le traitement de la dystrophie myotonique de type 1 et de type 2. L'invention concerne également des compositions comprenant les composés de formule (I). La présente invention concerne en outre de nouveaux composés qui sont des dimères de composés de formule (I).